ADVERTISEMENT
How K2 and Other Synthetic Cannabinoids Got Their Start in the Lab
How K2 and Other Synthetic Cannabinoids Got Their Start in the Lab
Originally intended for basic neuroscience research, the drugs were ultimately hijacked for illicit recreational use.
How K2 and Other Synthetic Cannabinoids Got Their Start in the Lab
How K2 and Other Synthetic Cannabinoids Got Their Start in the Lab

Originally intended for basic neuroscience research, the drugs were ultimately hijacked for illicit recreational use.

Originally intended for basic neuroscience research, the drugs were ultimately hijacked for illicit recreational use.

pharma, neuroscience

Pfizer to Halt Alzheimer’s and Parkinson’s Drug Research
Jim Daley | Jan 7, 2018 | 1 min read
The company’s recent effort to find new treatments for Alzheimer’s ended in disappointment.
ADVERTISEMENT